Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2021 1
2022 5
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean Ontlametse T. barengo (60 results)?
HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana.
Bareng OT, Moyo S, Zahralban-Steele M, Maruapula D, Ditlhako T, Mokaleng B, Mokgethi P, Choga WT, Moraka NO, Pretorius-Holme M, Mine MO, Raizes E, Molebatsi K, Motswaledi MS, Gobe I, Mohammed T, Gaolathe T, Shapiro R, Mmalane M, Makhema JM, Lockman S, Essex M, Novitsky V, Gaseitsiwe S. Bareng OT, et al. J Antimicrob Chemother. 2022 Apr 27;77(5):1385-1395. doi: 10.1093/jac/dkac056. J Antimicrob Chemother. 2022. PMID: 35229102 Free PMC article.
Doravirine-associated resistance mutations in antiretroviral therapy naïve and experienced adults with HIV-1 subtype C infection in Botswana.
Bareng OT, Seselamarumo S, Seatla KK, Choga WT, Bakae B, Maruapula D, Kelentse N, Moraka NO, Mokaleng B, Mokgethi PT, Ditlhako TR, Pretorius-Holme M, Mbulawa MB, Lebelonyane R, Bile EC, Gaolathe T, Shapiro R, Makhema JM, Lockman S, Essex M, Novitsky V, Mpoloka SW, Moyo S, Gaseitsiwe S. Bareng OT, et al. J Glob Antimicrob Resist. 2022 Dec;31:128-134. doi: 10.1016/j.jgar.2022.08.008. Epub 2022 Aug 13. J Glob Antimicrob Resist. 2022. PMID: 35973671 Free PMC article.
Patterns of pretreatment drug resistance mutations of very early diagnosed and treated infants in Botswana.
Moraka NO, Garcia-Broncano P, Hu Z, Ajibola G, Bareng OT, Pretorius-Holme M, Maswabi K, Maphorisa C, Mohammed T, Gaseitsiwe S, VanZyl GU, Kuritzkes DR, Lichterfeld M, Moyo S, Shapiro RL. Moraka NO, et al. Among authors: bareng ot. AIDS. 2021 Dec 1;35(15):2413-2421. doi: 10.1097/QAD.0000000000003041. AIDS. 2021. PMID: 34324451 Free PMC article. Clinical Trial.
HIV-1C in-House RNA-Based Genotyping Assay for Detection of Drug Resistance Mutations in Samples with Low-Level Viral Loads.
Bareng OT, Choga WT, Maphorisa ST, Seselamarumo S, Seatla KK, Mokgethi PT, Maruapula D, Mogwele ML, Ditshwanelo D, Moraka NO, Gobe I, Motswaledi MS, Makhema JM, Musonda R, Shapiro R, Essex M, Novitsky V, Moyo S, Gaseitsiwe S. Bareng OT, et al. Infect Drug Resist. 2022 Dec 22;15:7565-7576. doi: 10.2147/IDR.S388816. eCollection 2022. Infect Drug Resist. 2022. PMID: 36582452 Free PMC article.
Fostemsavir resistance-associated polymorphisms in HIV-1 subtype C in a large cohort of treatment-naïve and treatment-experienced individuals in Botswana.
Zuze BJL, Radibe BT, Choga WT, Bareng OT, Moraka NO, Maruapula D, Seru K, Mokgethi P, Mokaleng B, Ndlovu N, Kelentse N, Pretorius-Holme M, Shapiro R, Lockman S, Makhema J, Novitsky V, Seatla KK, Moyo S, Gaseitsiwe S. Zuze BJL, et al. Among authors: bareng ot. Microbiol Spectr. 2023 Dec 12;11(6):e0125123. doi: 10.1128/spectrum.01251-23. Epub 2023 Oct 12. Microbiol Spectr. 2023. PMID: 37823653 Free PMC article.
Genetic diversity in L1 ORF of human papillomavirus in women with cervical cancer with and without human immunodeficiency virus in Botswana and Kenya.
Tawe L, Choga WT, Paganotti GM, Bareng OT, Ntereke TD, Ramatlho P, Ditshwanelo D, Gaseitsiwe S, Kasvosve I, Ramogola-Masire D, Orang'o OE, Robertson E, Zetola N, Moyo S, Grover S, Ermel AC. Tawe L, et al. Among authors: bareng ot. BMC Infect Dis. 2022 Jan 27;22(1):95. doi: 10.1186/s12879-022-07081-3. BMC Infect Dis. 2022. PMID: 35086475 Free PMC article.
Predicted resistance to broadly neutralizing antibodies (bnAbs) and associated HIV-1 envelope characteristics among seroconverting adults in Botswana.
Moraka NO, Choga WT, Pema MN, Chawawa MK, Gobe I, Mokomane M, Bareng OT, Bhebhe L, Kelentse N, Mulenga G, Pretorius Holme M, Mohammed T, Koofhethile CK, Makhema JM, Shapiro R, Lockman S, Moyo S, Gaseitsiwe S. Moraka NO, et al. Among authors: bareng ot. Sci Rep. 2023 Oct 24;13(1):18134. doi: 10.1038/s41598-023-44722-2. Sci Rep. 2023. PMID: 37875518 Free PMC article.
Predicted broadly neutralizing antibody (bnAb) resistance and associated envelope characteristics of adults with HIV-1 seroconversion in Botswana.
Moraka NO, Choga WT, Pema MN, Chawawa MK, Gobe I, Mokomane M, Bareng OT, Bhebhe L, Kelentse N, Mulenga G, Pretorius-Holme M, Mohammed T, Koofhethile CK, Makhema JM, Shapiro R, Lockman S, Moyo S, Gaseitsiwe S. Moraka NO, et al. Among authors: bareng ot. Res Sq [Preprint]. 2023 Aug 29:rs.3.rs-3194948. doi: 10.21203/rs.3.rs-3194948/v1. Res Sq. 2023. PMID: 37693564 Free PMC article. Updated. Preprint.
Archived rilpivirine-associated resistance mutations among ART-naive and virologically suppressed people living with HIV-1 subtype C in Botswana: implications for cabotegravir/rilpivirine use.
Maruapula D, Moraka NO, Bareng OT, Mokgethi PT, Choga WT, Seatla KK, Kelentse N, Koofhethille CK, Zuze BJL, Gaolathe T, Pretorius-Holme M, Makhema J, Novitsky V, Shapiro R, Moyo S, Lockman S, Gaseitsiwe S. Maruapula D, et al. Among authors: bareng ot. J Antimicrob Chemother. 2023 Oct 3;78(10):2489-2495. doi: 10.1093/jac/dkad258. J Antimicrob Chemother. 2023. PMID: 37585352 Free PMC article.
16 results